
Maintenance therapy helps deter undetectable cancer that may exist after initial treatment.

Maintenance therapy helps deter undetectable cancer that may exist after initial treatment.

Patients with blood cancer who have higher levels of neurofilament light chains — which indicate brain injury — were found to be more likely to develop neurotoxicity after CAR-T cell therapy, according to recent research.

I used to love October, but after being diagnosed with cancer on Oct. 12 — twice — I dread the month.

While I’m usually a private person, it’s important to me to share my three bouts with cancer so that others will learn their bodies and their family history.

The Food and Drug Administration approved Retevmo for the treatment of patients with advanced or metastatic non-small cell lung cancer with a rearranged RET gene fusion.

Cancer made me more empathetic, as well as an advocate for the HPV vaccine.

Three out of four women with lung cancer reported experiencing moderate to severe sexual dysfunction, a survey shows.

It’s good that celebrities with cancer raise awareness about the disease, but I think that they can do more.

Melanoma of the skin has been shown to be greatly associated with exposure to sunlight, whereas uveal melanoma — commonly known as cancer of the eye — is not.

The Food and Drug Administration approved Pedmark for the prevention of chemotherapy-induced hearing loss in pediatric patients with localized, nonmetastatic solid cancers.

Although patients treated with the combination did not have significant improvements in survival, telaglenastat and Cabometyx did not increase the rate of side effects in patients.

Pets may be like family to some individuals but caring for them during illnesses such as cancer may force some to make a difficult decision.

When my husband was diagnosed with prostate cancer in his mid 40s, we opted for a more aggressive treatment strategy, which led him being cancer-free and able to enjoy a healthy sex life.

Years ago, the goal of head and neck cancer treatment was strictly focused on a cure. Now, there has been a slight change in approach to improve survival rates while preserving quality of life.

The Food and Drug Administration granted a priority review for Tukysa plus Herceptin for patients with pretreated, metastatic colon cancer.

An expert explains how antibody drug conjugates work to treat cancer.


Opting for hormonal or nonhormonal fertility preservation is unlikely to affect a woman’s risk for death or disease recurrence after receiving a diagnosis of breast cancer.

I never thought I’d admit experiencing fear of cancer recurrence, but at a recent medical appointment I realized that I struggle with this fear daily.

Long-term outcomes from this trial confirm the benefit of treatment with chemoradiotherapy over chemotherapy alone for patients with muscle-invasive bladder cancer.

CURE® surveyed its audience to see how their cancer diagnosis affected their mental health. Here’s what they had to say.

Despite my mother and grandmother’s history with the disease, I never thought I would one day receive a colon cancer diagnosis.

Black women were more likely to benefit from neoadjuvant endocrine therapy for early-stage breast cancer, however, their outcomes were inferior to White women when it came to late-stage disease, recent research showed.

I pretend I’m at a spa day as an oncology nurse in a hazmat suit unhooks me from the intravenous drip machine.

Over the past five years, CAR-T cell therapy has improved outcomes for many patients with blood cancer. Here’s what patients need to know about the immune-based treatment.

Extra years with my family meant missing out on a free trip granted to patients with cancer who have children under the age of 18 — and I’m OK with that.

From the delay of some health care services in the United Kingdom due to Queen Elizabeth II’s funeral to actor Ryan Reynolds broadcasting his colonoscopy — including the finding of a pre-cancerous polyp — here’s what’s happening in the cancer space this week.

Botensilimab will be evaluated in certain patients with colorectal cancer and melanoma, a type of skin cancer, in two recently launched clinical trials.

Although rates of pathologic complete response to neoadjuvant — also known as presurgical — chemotherapy were lower in men than women with breast cancer, this may highlight an area of further research of treating this cancer in men.

As I face the end of my life due to metastatic colorectal cancer, I’m preparing my loved ones for my death — from determining who gets my stuff to writing my eulogy and making my memorial service playlist.